S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The Safest Option in Trades! (Ad)pixel
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The Safest Option in Trades! (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Brazil holds historic election with Lula against Bolsonaro
The Safest Option in Trades! (Ad)pixel
US shift away from coal hits tribal community in New Mexico
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The Safest Option in Trades! (Ad)pixel
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The Safest Option in Trades! (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Brazil holds historic election with Lula against Bolsonaro
The Safest Option in Trades! (Ad)pixel
US shift away from coal hits tribal community in New Mexico
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The Safest Option in Trades! (Ad)pixel
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The Safest Option in Trades! (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Brazil holds historic election with Lula against Bolsonaro
The Safest Option in Trades! (Ad)pixel
US shift away from coal hits tribal community in New Mexico
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The Safest Option in Trades! (Ad)pixel
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The Safest Option in Trades! (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Brazil holds historic election with Lula against Bolsonaro
The Safest Option in Trades! (Ad)pixel
US shift away from coal hits tribal community in New Mexico
Allies aim for risky Russian oil price cap as winter nears
NASDAQ:ISPC

iSpecimen - ISPC Stock Forecast, Price & News

$1.65
-0.01 (-0.60%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.58
$1.74
50-Day Range
$1.51
$2.58
52-Week Range
$1.51
$28.98
Volume
117,146 shs
Average Volume
970,470 shs
Market Capitalization
$14.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.13

iSpecimen MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
634.8% Upside
$12.13 Price Target
Short Interest
Healthy
1.93% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.36mentions of iSpecimen in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

308th out of 1,095 stocks

Commercial Physical Research Industry

7th out of 16 stocks

About iSpecimen

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Stock News Headlines

See More Headlines
Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Company Calendar

Last Earnings
8/04/2022
Today
10/02/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ISPC
Fax
N/A
Employees
59
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.13
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$4.25
Forecasted Upside/Downside
+634.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-8,960,000.00
Pretax Margin
-84.89%

Debt

Sales & Book Value

Annual Sales
$11.14 million
Book Value
$3.41 per share

Miscellaneous

Free Float
6,016,000
Market Cap
$14.65 million
Optionable
Not Optionable
Beta
2.34

Key Executives

  • Dr. Christopher J. Ianelli M.D. (Age 54)
    Ph.D., Founder, Pres, CEO & Director
    Comp: $440k
  • Ms. Tracy Wilson Curley (Age 60)
    CFO & Treasurer
    Comp: $367k
  • Ms. Jill Mullan (Age 57)
    COO, Sec. & Director
    Comp: $391.25k
  • Mr. Benjamin Bielak (Age 52)
    Chief Information Officer
    Comp: $334k
  • Mr. Eric Langlois
    Sr. VP of Sales & Bus. Devel.
  • Ms. Carly Lejnieks
    VP of Marketing
  • Ms. Emily Hubbard
    VP of Site Management & Devel.
  • Mr. David Wages M.D.
    Ph.D., Chief Medical Officer













ISPC Stock - Frequently Asked Questions

Should I buy or sell iSpecimen stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iSpecimen in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ISPC shares.
View ISPC analyst ratings
or view top-rated stocks.

What is iSpecimen's stock price forecast for 2022?

2 Wall Street research analysts have issued 12-month price targets for iSpecimen's shares. Their ISPC share price forecasts range from $4.25 to $20.00. On average, they predict the company's share price to reach $12.13 in the next year. This suggests a possible upside of 634.8% from the stock's current price.
View analysts price targets for ISPC
or view top-rated stocks among Wall Street analysts.

How have ISPC shares performed in 2022?

iSpecimen's stock was trading at $7.81 at the start of the year. Since then, ISPC shares have decreased by 78.9% and is now trading at $1.65.
View the best growth stocks for 2022 here
.

When is iSpecimen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our ISPC earnings forecast
.

How were iSpecimen's earnings last quarter?

iSpecimen Inc. (NASDAQ:ISPC) announced its earnings results on Thursday, August, 4th. The company reported ($0.30) EPS for the quarter. The business had revenue of $2.34 million for the quarter. iSpecimen had a negative trailing twelve-month return on equity of 36.25% and a negative net margin of 84.89%.

When did iSpecimen IPO?

(ISPC) raised $20 million in an IPO on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

What is iSpecimen's stock symbol?

iSpecimen trades on the NASDAQ under the ticker symbol "ISPC."

How do I buy shares of iSpecimen?

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iSpecimen's stock price today?

One share of ISPC stock can currently be purchased for approximately $1.65.

How much money does iSpecimen make?

iSpecimen (NASDAQ:ISPC) has a market capitalization of $14.65 million and generates $11.14 million in revenue each year.

How can I contact iSpecimen?

The official website for the company is ispecimen.com. The company can be reached via phone at 781-301-6700 or via email at ispecimen@kcsa.com.

This page (NASDAQ:ISPC) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.